[go: up one dir, main page]

BR0111685A - sequências de nucleotìdeos e amino-ácidos de fatores de oócito para alteração de crescimento folicular do ovário in vivo ou in vitro - Google Patents

sequências de nucleotìdeos e amino-ácidos de fatores de oócito para alteração de crescimento folicular do ovário in vivo ou in vitro

Info

Publication number
BR0111685A
BR0111685A BRPI0111685-1A BR0111685A BR0111685A BR 0111685 A BR0111685 A BR 0111685A BR 0111685 A BR0111685 A BR 0111685A BR 0111685 A BR0111685 A BR 0111685A
Authority
BR
Brazil
Prior art keywords
vitro
vivo
amino acid
acid sequences
follicular growth
Prior art date
Application number
BRPI0111685-1A
Other languages
English (en)
Inventor
Susan May Galloway
George Henry Davis
Kenneth Pattrick Mcnatty
Olli Visa-Pekka Ritvos
Kaisha Niina Johan Vuojolainen
Mika Petri Esaias Laitinen
Jenny Juengal
Original Assignee
Biotechvisions Ltd
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechvisions Ltd, Agres Ltd filed Critical Biotechvisions Ltd
Publication of BR0111685A publication Critical patent/BR0111685A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SEQUêNCIAS DE NUCLEOTTìDEOS E AMINO-áCIDOS DE FATTORES DE OóCITO PARA ALTERAçãO DE CRESCIMENTO FOLICULAR DO OVáRIO IN VIVO OU IN VITRO A presente invenção se refere a seqüências de nucleotídeo ou amino-ácido de fatores de oócito para alteração de crescimento folicular de ovário in vivo ou in vitro. A presente invenção também se refere a novos polipeptídeos homodeméricos ou heterodiméricos e seu uso para alteração de crescimento folicular de ovário de mamífero in vivo ou in vitro. Em particular, a invenção se refere amplamente a imunização ativa ou passiva contra esses polipeptídeos homo- ou heterodiméricos ou fragmentos funcionais ou variantes dos mesmos a fim de alterar o crescimento folicular in vivo ou in vitro.
BRPI0111685-1A 2000-06-15 2001-06-15 sequências de nucleotìdeos e amino-ácidos de fatores de oócito para alteração de crescimento folicular do ovário in vivo ou in vitro BR0111685A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ502796A NZ502796A (en) 2000-06-15 2000-06-15 Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
PCT/NZ2001/000113 WO2001096393A2 (en) 2000-06-15 2001-06-15 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro

Publications (1)

Publication Number Publication Date
BR0111685A true BR0111685A (pt) 2007-05-29

Family

ID=19927744

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0111685-1A BR0111685A (pt) 2000-06-15 2001-06-15 sequências de nucleotìdeos e amino-ácidos de fatores de oócito para alteração de crescimento folicular do ovário in vivo ou in vitro

Country Status (12)

Country Link
US (2) US7098183B2 (pt)
EP (1) EP1294755A2 (pt)
JP (1) JP2004503236A (pt)
CN (1) CN1294143C (pt)
AU (1) AU784276C (pt)
BR (1) BR0111685A (pt)
CA (1) CA2410532A1 (pt)
MX (1) MXPA02012378A (pt)
NZ (1) NZ502796A (pt)
RU (1) RU2270862C2 (pt)
WO (1) WO2001096393A2 (pt)
ZA (1) ZA200210122B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
EP1522311A1 (fr) 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
CN101272804A (zh) * 2005-07-18 2008-09-24 阿德莱德研究及创新控股有限公司 调节颗粒细胞的凋亡
CN101525662B (zh) * 2009-04-02 2011-08-17 西北农林科技大学 一种用gdf5基因预示和鉴定秦川牛体尺大小的分子标记方法
CN108977553B (zh) * 2018-09-05 2021-08-31 湖北省农业科学院畜牧兽医研究所 蛋鸭环状RNA circ_13267及其检测试剂、方法与应用
CN108977554B (zh) * 2018-09-05 2021-08-31 湖北省农业科学院畜牧兽医研究所 蛋鸭环状RNA circ_13034及其检测试剂、方法与应用
CN116102620A (zh) * 2022-12-07 2023-05-12 童国庆 卵泡液来源的多肽、化学合成物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
EP1011712B1 (en) * 1997-09-19 2004-02-11 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Combination of cytokines having neurotrophic activity
US6872698B2 (en) * 1998-07-06 2005-03-29 Scion Pharmaceuticals, Inc. Methods for treating neurological injuries and disorders
WO2000032222A1 (en) * 1998-12-01 2000-06-08 Akzo Nobel N.V. Improvement of folliculogenesis
NZ500844A (en) * 2000-05-05 2003-06-30 Agres Ltd Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate

Also Published As

Publication number Publication date
US20040267003A1 (en) 2004-12-30
US7098183B2 (en) 2006-08-29
WO2001096393A3 (en) 2002-08-08
RU2270862C2 (ru) 2006-02-27
AU6795001A (en) 2001-12-24
US20060253912A1 (en) 2006-11-09
WO2001096393A2 (en) 2001-12-20
ZA200210122B (en) 2003-09-30
JP2004503236A (ja) 2004-02-05
WO2001096393A9 (en) 2002-11-28
EP1294755A2 (en) 2003-03-26
RU2003100883A (ru) 2005-01-20
CA2410532A1 (en) 2001-12-20
AU784276C (en) 2007-11-15
NZ502796A (en) 2003-02-28
AU784276B2 (en) 2006-03-02
CN1294143C (zh) 2007-01-10
CN1636012A (zh) 2005-07-06
MXPA02012378A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
Hirai et al. Degradation of transcription factors, c‐Jun and c‐Fos, by calpain
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
BRPI0516176A (pt) polipeptìdeo, dna, microorganismo, e, processo para produzir l-arginina, l-ornitina ou l-citrulina
NO2017027I1 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
BR0014945A (pt) Modificação pós-traducional de proteìnas recombinantes produzidas em plantas
BR0111685A (pt) sequências de nucleotìdeos e amino-ácidos de fatores de oócito para alteração de crescimento folicular do ovário in vivo ou in vitro
WO2003073238A3 (en) Computational method for designing enzymes for incorporation of amino acid analogs into proteins
ATE500323T1 (de) Subtilisin-variante
Wang et al. The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains
AR036272A1 (es) Genes de metiltransferasas y usos de los mismos
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
EP1548107A4 (en) CHROMOPROTEIN AND FLUORO PROTEINS
AU2003222717A8 (en) Streptavidin-binding peptide
DE602004023970D1 (de) Fluoreszenzproteine
MXPA03005218A (es) Peptidos y/o proteinas y uso de los mismos para la produccion de un medicamento terapeutico y/o profilactico.
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE60228136D1 (de) Cytokin-proteinfamilie
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
Abe et al. Extra domain A and type III connecting segment of fibronectin in assembly and cleavage
ATE500840T1 (de) Verwendung von gilz-protein zur modulation einer antigenspezifischen immunantwort
ATE458037T1 (de) Grosstechnisch geeigneter mikroorganismus
ATE452141T1 (de) Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen
DE50208775D1 (de) Eine dna-sequenz des enzyms phospholipase a1 aus dem ciliaten tetrahymena und die verwendung dieser
PT788549E (pt) Sequencias reguladoras de acidos nucleicos e utilizacoes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.